# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-23-102107
Filing Date
2023-04-14
Accepted
2023-04-14 16:17:58
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d477057dars.pdf | ARS | 2276056
| Complete submission text file | 0001193125-23-102107.txt |  | 3136590

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33137 | Film No.: 23821399
SIC: 2834 Pharmaceutical Preparations